Detalhe da pesquisa
1.
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs.
Blood
; 137(25): 3507-3517, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651883
2.
HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia.
Haematologica
; 105(4): 1042-1054, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289209
3.
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.
Blood
; 120(16): 3271-9, 2012 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-22932792
4.
CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?
Hemasphere
; 7(12): e988, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38044959
5.
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia.
Sci Rep
; 13(1): 16950, 2023 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37805613
6.
Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges.
Front Oncol
; 12: 837531, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35265527
7.
Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights.
Front Oncol
; 12: 917115, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35734588
8.
Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia.
Cancers (Basel)
; 13(15)2021 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359757
9.
Targeting HIF-1α Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL.
Cancers (Basel)
; 13(12)2021 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34207596
10.
CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia.
Cancers (Basel)
; 13(16)2021 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34439393
11.
Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia.
Front Immunol
; 11: 594556, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33312177
12.
Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs.
Cancers (Basel)
; 12(2)2020 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31979293
13.
Magic pills: new oral drugs to treat chronic lymphocytic leukemia.
Expert Opin Pharmacother
; 18(4): 411-425, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28234562
14.
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia.
Oncotarget
; 8(2): 3274-3288, 2017 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27906678
15.
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma.
Oncoimmunology
; 4(11): e1047580, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26451323
16.
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.
Oncotarget
; 6(30): 29833-46, 2015 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26284584